Novo Nordisk
NVO
HK$483.84
Share price
1.73%
Change (1 day)
-51.99%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
EPS for Novo Nordisk (NVO)
EPS in 2023 (TTM): HK$22.37
According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is HK$22.16. In 2022 the company made an earnings per share (EPS) of HK$16.84 an increase over its 2021 EPS that were of HK$15.45.
EPS history for Novo Nordisk from 1996 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | HK$22.37 | 32.81% |
| 2022 | HK$16.84 | 9.01% |
| 2021 | HK$15.45 | 15.08% |
| 2020 | HK$13.42 | 14.83% |
| 2019 | HK$11.69 | -1.68% |
| 2018 | HK$11.89 | 4.96% |
| 2017 | HK$11.33 | 31.08% |
| 2016 | HK$8.64 | -10.33% |
| 2015 | HK$9.64 | 13.91% |
| 2014 | HK$8.46 | 4.03% |
| 2013 | HK$8.13 | -28.81% |
| 2012 | HK$11.42 | 108.9% |
| 2011 | HK$5.47 | 25.59% |
| 2010 | HK$4.35 | 35.01% |
| 2009 | HK$3.22 | -9.17% |
| 2008 | HK$3.55 | 61.35% |
| 2007 | HK$2.20 | 28.96% |
| 2006 | HK$1.71 | 25.63% |
| 2005 | HK$1.36 | 4.17% |
| 2004 | HK$1.30 | 13.55% |
| 2003 | HK$1.15 | 36.87% |
| 2002 | HK$0.84 | -6.99% |
| 2001 | HK$0.90 | 21.56% |
| 2000 | HK$0.74 | 49.45% |
| 1999 | HK$0.50 | 3.78% |
| 1998 | HK$0.48 | 12.15% |
| 1997 | HK$0.43 | 24.74% |
| 1996 | HK$0.34 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | HK$14.43 | -34.87% | 🇺🇸 USA |
 | HK$42.12 | 90.12% | 🇺🇸 USA |
 | HK$30.80 | 39.02% | 🇺🇸 USA |
 | HK$24.67 | 11.36% | 🇫🇷 France |